Battling Bone Disease: New Drugs Strengthen the Osteoporosis Market

ISSN： 1176-3469

Source： Pharmaceutical & Diagnostic Innovation, Vol.2, Iss.6, 2004-11, pp. : 3-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Biochemical Markers of Bone Turnover in the Clinical Development of Drugs for Osteoporosis and Metastatic Bone Disease: Potential Uses and Pitfalls

By Cremers Serge Garnero Patrick

Drugs, Vol. 66, Iss. 16, 2006-01 ,pp. : 2031-2058

Adis International

Access to resources Recommend Favorite

Zoledronic acid: an advance in tumour bone disease therapy and a new hope for osteoporosis

By Body Jean-Jacques

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 4, 2003-04 ,pp. : 567-580

Informa Healthcare

Access to resources Recommend Favorite

New findings with old drugs for osteoporosis

By Doggrell Sheila A

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 3, 2009-02 ,pp. : 513-516

Informa Healthcare

Access to resources Recommend Favorite

Statins: new drugs for treating osteoporosis?

By Whitfield J.F.

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 3, 2001-03 ,pp. : 417-417

Informa Healthcare

Access to resources Recommend Favorite

Statins: new drugs for treating osteoporosis?

By Whitfield J.F.

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 11, 2000-11 ,pp. : 2505-2518

Informa Healthcare

Access to resources Recommend Favorite